A 54 year-old African-American male has been diagnosed with chronic myeloid leukemia a week ago. His current medical history is significant for gout and hypertension. As he is being prepared for his chemotherapy you’re concerned about the development of hyperuricemia. You ordered some laboratory tests that revealed, among other findings, a uric acid level of 9.8 mg/dl. Which of the following is a recombinant urate oxidase that can be effective in the management of tumor lysis syndrome?
